^
BIOMARKER:

MSI-L/dMMR

i
Other names: MSI (Microsatellite instability)
Related biomarkers:
News
Twitter
Trials
MSI-L/dMMR
Small Intestinal Carcinoma
dostarlimab
Sensitive: A2 - Guideline
MSI-L/dMMR
Pancreatic Ductal Adenocarcinoma
nivolumab
Sensitive: C3 – Early Trials
MSI-L/dMMR
Pancreatic Ductal Adenocarcinoma
ipilimumab
Sensitive: C3 – Early Trials
MSI-L/dMMR
Pancreatic Ductal Adenocarcinoma
pembrolizumab
Sensitive: C3 – Early Trials
MSI-L/dMMR
CRC
camrelizumab + SHR7390
Sensitive: C3 – Early Trials